Chinese researchers will be starting a human trial investigating a CRISPR/Cas9-based therapy for metastatic non-small cell lung cancer next month, Nature News reports.
Chinese researchers will be starting a human trial investigating a CRISPR/Cas9-based therapy for metastatic non-small cell lung cancer next month, Nature News reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.